AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Avalo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$11.59+0.32 (+2.84%)
Close on Oct 19, 2026
- Market cap
- $505.35M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Dec 29, 2023 | 1-for-240 reverse | Earlier per-share figures multiplied by 240 |
| Dec 28, 2023 | 1-for-240 reverse | Earlier per-share figures multiplied by 240 |
| Jul 8, 2022 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jul 7, 2022 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |